Ocular Therapeutix
OCUL
OCUL
135 hedge funds and large institutions have $224M invested in Ocular Therapeutix in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 17 closing their positions.
Holders
135
Holders Change
+8
Holders Change %
+6.3%
% of All Funds
2.13%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
26
Increased
42
Reduced
38
Closed
17
Calls
$4.99M
Puts
$1.99M
Net Calls
+$3M
Net Calls Change
+$932K
Top Buyers
Top Sellers
1 |
1
Morgan Stanley
New York
|
$1.2M |
2 |
2
D.E. Shaw & Co
New York
|
$3.39M |
3 |
3
Norges Bank
Oslo,
Norway
|
$617K |
4 |
OM
4
Opaleye Management
Boston,
Massachusetts
|
$29.8M |
5 |
5
Citadel Advisors
Miami,
Florida
|
$6.45M |